Secukinumab (anti-IL-17A) (Cosentyx, AIN457) is a human IgG1kappa monoclonal antibody that binds to the protein interleukin (IL)-17A, and is applied for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. MW=147.9 kDa.
CAS Number:
[1229022-83-6]
* VAT and and shipping costs not included. Errors and price changes excepted